CA1077846A - Pharmaceutical compositions having an action on the central nervous system - Google Patents

Pharmaceutical compositions having an action on the central nervous system

Info

Publication number
CA1077846A
CA1077846A CA283,049A CA283049A CA1077846A CA 1077846 A CA1077846 A CA 1077846A CA 283049 A CA283049 A CA 283049A CA 1077846 A CA1077846 A CA 1077846A
Authority
CA
Canada
Prior art keywords
fluoro
amino
benzylidenyl
alpha
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA283,049A
Other languages
English (en)
French (fr)
Inventor
Giuseppe Bartholini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7622045A external-priority patent/FR2358881A1/fr
Priority claimed from FR7719390A external-priority patent/FR2453643A2/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of CA1077846A publication Critical patent/CA1077846A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
CA283,049A 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system Expired CA1077846A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7622045A FR2358881A1 (fr) 1976-07-20 1976-07-20 Composition pharmaceutique active sur le systeme nerveux central
FR7719390A FR2453643A2 (fr) 1977-06-24 1977-06-24 Compositions pharmaceutiques actives sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
CA1077846A true CA1077846A (en) 1980-05-20

Family

ID=26219550

Family Applications (1)

Application Number Title Priority Date Filing Date
CA283,049A Expired CA1077846A (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system

Country Status (11)

Country Link
JP (1) JPS5326327A (enrdf_load_stackoverflow)
AU (1) AU508753B2 (enrdf_load_stackoverflow)
CA (1) CA1077846A (enrdf_load_stackoverflow)
DE (1) DE2732614A1 (enrdf_load_stackoverflow)
GB (1) GB1556567A (enrdf_load_stackoverflow)
IE (1) IE45454B1 (enrdf_load_stackoverflow)
IL (1) IL52550A (enrdf_load_stackoverflow)
LU (1) LU77796A1 (enrdf_load_stackoverflow)
NL (1) NL7708055A (enrdf_load_stackoverflow)
NZ (1) NZ184666A (enrdf_load_stackoverflow)
SE (1) SE7708349L (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
NZ184666A (en) 1980-04-28
JPS5326327A (en) 1978-03-11
NL7708055A (nl) 1978-01-24
AU508753B2 (en) 1980-04-03
SE7708349L (sv) 1978-01-21
IE45454B1 (en) 1982-08-25
GB1556567A (en) 1979-11-28
LU77796A1 (enrdf_load_stackoverflow) 1977-10-25
IE45454L (en) 1978-01-20
IL52550A0 (en) 1977-10-31
DE2732614A1 (de) 1978-01-26
AU2715177A (en) 1979-01-25
IL52550A (en) 1981-03-31

Similar Documents

Publication Publication Date Title
PE20230860A1 (es) Compuestos de dihidroquinolinsulfonamida de ciclobutilo
HUP0402376A2 (hu) Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények
AR008386A1 (es) DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.
ES2112332T3 (es) Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico.
KR910006218A (ko) 2-아미도테트라린 치환유도체와 이 치환유도체를 포함하는 제약학적 조성물 및 이를 사용한 치료방법
KR950010888A (ko) 평활근세포 증식 및 재발협착증을 억제하는 방법
ES2101449T3 (es) Inhibicion de la seborrea y el acne.
RU94044454A (ru) Ингибитор аутоимунных заболеваний
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
CO5200778A1 (es) Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de b enzimidazol, administrada para prevenir y tratar el cancer e inhibir la metastasis
RU94037233A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения лекарственноустойчивых новообразований
KR890003691A (ko) 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
NO923911D0 (no) Nye 17beta-substituerte aza-androstan derivater
CA1077846A (en) Pharmaceutical compositions having an action on the central nervous system
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
Wang et al. Evaluation of Anti‐inflammatory and Analgesic Effects of Synthesized Derivatives of Ibuprofen
AU3623399A (en) Use of benzofuroxan derivatives in treating angina pectoris
IL98391A0 (en) Substituted phenylacetylenes,their preparation and pharmaceutical compositions containing them
FI923759A0 (fi) Terapeutiska bensazapinfoereningar.
GR3021194T3 (en) Unbridged bis-aryl carbinol derivatives, compositions and methods of use.
ATE8389T1 (de) Amino-alkoxy-pyrazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3484375D1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
CH625122A5 (en) Pharmaceutical compositions with an action on the central nervous system

Legal Events

Date Code Title Description
MKEX Expiry